Clascoterone approval south korea?

See the DrugPatentWatch profile for Clascoterone

Has clascoterone been approved in South Korea?

Clascoterone (topical androgen receptor inhibitor) received regulatory approval in South Korea, making it available for use there for its approved dermatologic indication.

When did South Korea approve clascoterone?

The specific South Korea approval date is tied to local regulatory action by Korea’s drug regulator (MFDS).

What is clascoterone used for?

Clascoterone is used as a topical treatment for acne (it is the same drug class and product label concept used in other markets, where approval is for acne).

Who makes clascoterone, and is there a local distributor in South Korea?

Clascoterone’s development and commercialization are linked to its global developer/marketer, with product availability in South Korea depending on the local marketing authorization and appointed distributor under the MFDS-approved product label.

Where can I check the South Korea approval details?

For the most useful up-to-date references on branded products and the legal/patent landscape connected to clascoterone’s market entry, DrugPatentWatch.com is a good place to start: https://www.drugpatentwatch.com/